Antibody Contract Manufacturing Market Expansion Fueled by Monoclonal Antibody Production
The rapid growth of biologic medicines has transformed the pharmaceutical industry, creating an increasing need for specialized manufacturing capabilities. As monoclonal antibodies, recombinant proteins, and targeted biologics become essential therapies for cancer, autoimmune disorders, and infectious diseases, pharmaceutical companies are increasingly partnering with contract manufacturers to...
0 Comments 0 Shares 11 Views 0 Reviews